The Beacon ® optofluidic platform maintains ... thus quickening the process of antibody (drug) discovery. The company also offers mouse monoclonal antibody humanization services.

It is unclear why an independent data safety monitoring board recommended the suspension of Pliant’s Phase IIb/III BEACON-IPF ...

biological drug development, and other applications. Sino Biological offers a variety of fast antibody production services, including fast mouse monoclonal antibody production, fast rabbit polyclonal ...

Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed SOUTH SAN FRANCISCO, ...

The Company is actively monitoring the current patients in the BEACON-IPF trial ... Bexotegrast has received Fast Track and Orphan Drug Designations from the FDA, demonstrating regulatory support ...

Jasper Therapeutics will present preliminary data from the BEACON study of briquilimab, which could enhance the visibility and interest in their novel antibody therapy. The inclusion of Dr.